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Escherichia coli 
and Klebsiella 
pneumoniae  
Carbapenemase  
in Long-term Care 
Facility, Illinois, USA
To the Editor: Escherichia coli 
harboring Klebsiella pneumoniae car-
bapenemases (KPCs) are now rarely 
being reported. Worldwide, KPC-2 has 
been detected in Israel and the People’s 
Republic of China (1,2). Within the 
United States, carbapenem-resistant E. 
coli carrying blaKPC has been isolated 
in New Jersey (3) and Cleveland, Ohio 
(4), and 7 carbapenem-resistant E. coli 
isolates were obtained from 3 differ-
ent hospitals in Brooklyn, New York 
(5). Urban et al. (6) recently reported 
9 KPC-2 and KPC-3 carbapenemases 
in urinary E. coli isolates from 7 long-
term care facilities. We report such an 
isolate from a resident of a long-term 
care facility.
This case involved a 68-year-old 
female resident of a long-term care 
facility in Centralia, Illinois, who had 
multiple chronic medical problems, 
including cerebral palsy, a seizure 
disorder, and recurrent urinary tract 
infections. A urine culture grew >105 
CFU/mL of E. coli susceptible to ami-
kacin, gentamicin, tobramycin, pip-
eracillin/tazobactam, trimethoprim/
sulfamethoxazole, imipenem, and ni-
trofurantoin. Tigecycline susceptibil-
ity was not determined. Trimethoprim/
sulfamethoxazole therapy was initi-
ated. Follow-up urine culture almost 
3 weeks later again grew >105 CFU/
mL of E. coli, now susceptible to ami-
kacin, gentamicin, tobramycin, nitro-
furantoin, and tigecycline. The isolate 
was resistant to imipenem and mero-
penem. A modified Hodge test demon-
strated production of a carbapenemase 
(7), and the blaKPC gene was detected 
by PCR at the Centers for Disease 
Control and Prevention (CDC). The 
patient was treated with a 10-day 
course of nitrofurantoin, 100 mg by 
gastrostomy tube 2× per day. Chart 
review indicated that contact precau-
tions were instituted only after discov-
ery of the second E. coli isolate.
Seventeen days later, a repeat 
urine culture grew >105 CFU/mL of K. 
pneumoniae susceptible only to ami-
kacin, gentamicin, tobramycin, and 
tigecycline. No treatment was given. 
Follow-up urine culture grew >105 
CFU/mL of K. pneumoniae again with 
a similar resistance pattern. The modi-
fied Hodge test result was positive (7) 
and was confirmed as blaKPC positive 
by PCR at CDC. The resident was 
transferred to an acute care facility for 
further evaluation and was treated with 
amikacin. At completion of therapy, a 
repeat urine culture was negative for 
organisms.
Our case, like that of Urban et al. 
(6), involved a urinary isolate from a 
resident of a long-term care facility. 
As increasing numbers of resistant 
gram-negative rods colonize such 
patients, the patients may acquire a 
bacterium carrying a KPC plasmid 
conferring broad-spectrum resistance 
as described in our patient. These plas-
mids may then be laterally transferred 
to other gram-negatives, which may 
have occurred in this case.
Our case underscores the gravity 
of the evolutionary process of emer-
gent, multidrug–resistant enterobac-
teriaceae. Even though E. coli strains 
that harbor carbapenemase genes are 
not ubiquitous, additional therapeutic 
interventions are needed to prevent 
the spread of these bacteria, which are 
likely to infect increasing numbers of 
patients.
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Bedbugs and 
Healthcare- 
associated  
Dermatitis, France
To the Editor: Bedbugs (Cimex 
lectularius) are hematophagous in-
sects. Adults are 4–6 mm long, flat-
tened, oval and wingless, and brown 
to brownish–red (Figure, panel A) (1). 
They may feed in the wild on birds or 
bats (2), but they are mainly associ-
ated with human dwellings and can 
be found on furniture and clothing (3). 
Because bedbugs are nocturnal and 
feed painlessly only in the dark, while 
humans sleep, initial bedbug prolif-
eration usually goes unnoticed until 
several weeks later when the patient 
discovers a pruritic cutaneous erup-
tion of unknown origin (4). Decades 
ago, bedbugs were frequently found 
worldwide, but reports of cases in 
industrialized countries have progres-
sively declined, probably the result of 
improved living conditions (3). They 
nonetheless remain a pest in less-
developed countries and in the wild 
(5). The past 10 years have seen the 
revival of this insect in industrialized 
countries (3,6,7). Increasing reports 
describe isolated cases or bedbugs 
spreading throughout a single building 
(8). We report an outbreak of health-
care-associated dermatitis caused by 
bedbugs in a hospital nursing home in 
Cannes, French Riviera.
In July 2007, Mrs. Q arrived, with 
her bed and mattress, for admission 
to a single room in a hospital nursing 
home. This facility has 112 rooms lo-
cated on 2 floors, each having A and 
B wings. Mrs. Q’s first lesions, di-
agnosed as insect bites, appeared in 
October 2007. Concomitantly, Mrs. 
T, a long-term resident of the room 
across the hall (1.5 m away), devel-
oped similar lesions. Examination of 
Mrs. Q’s room led to the discovery of 
an aggregation of 200 C. lectularius 
bedbugs beneath her mattress. In Mrs. 
T’s room, 15 bedbugs were identified 
(Figure 1, panel B). Suspected insect 
excreta were also found in another 
nearby room. A private company con-
ducted a nonspecific pest-control in-
tervention in these 3 rooms.
In November 2007, another 2 
residents in rooms located 3 and 6 m 
away from Mrs. Q’s had insect-bite 
dermatitis: 15 bedbugs were found in 
each room. Over a 3-week period, the 
nursing home staff performed the sec-
ond pest-control intervention in these 
2 infested rooms and also treated 10 
adjacent rooms. They disassembled 
furniture and applied insecticides 
to furniture, room corners (imipro-
thrine and cypermethrine), and cloth-
ing (esdepallethrine and piperonyl 
butoxide).
No additional skin lesions oc-
curred during the next 4 months, and 
no new resident was admitted. In 
March 2008, a new long-term resident 
developed similar bedbug-dermatitis 
lesions (Figure, panel C); 12 C. lectu-
larius bedbugs were found in his room 
(33 m from Mrs. Q’s room, same floor, 
wing B). This time, a specialized pri-
vate company conducted the pest-
control intervention over a 2-month 
period in the 56 rooms on the second 
floor (wings A and B); they treated fur-
niture and clothing and placed silicone 
sealer around doors and floorboards 
to obstruct potential pest refuges. All 
furniture was removed, disassembled, 
and washed. When no bedbugs or eggs 
were found, bendiocarb was applied 
preventively; otherwise, curative d-
trans-tetramethrin was applied (3). No 
further infestation has been observed.
Three pest-control interventions 
were required to eliminate these in-
festations. The first was not specific 
for bedbugs, and the second was not 
sufficiently extensive. Only specific 
and extensive insecticide application 
achieved elimination. The temporal–
spatial distribution of dermatitis in this 
facility suggests 2 types of transmis-
sion: during the first 2 waves, spon-
taneous movement of the bedbugs is 
the most likely hypothesis because 
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